Zhenqiu R. Chen

State Key Laboratory Of Traditional Chinese Medicine Syndromes
Guangzhou, 510405, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Targeting the neuropilin 1/interferon γ axis restores glucocorticoid-suppressed T cell function and rescues bone formation to prevent steroid-induced osteonecrosis.

Targeting the neuropilin 1/interferon γ axis restores glucocorticoid-suppressed T cell function and rescues bone formation to prevent steroid-induced osteonecrosis.

Journal: Bone & joint research

Published: July 07, 2026

Cajaninstilbene Acid targets TNF-α-mediated mitochondrial translocation to restore osteogenic-osteoclastic coupling equilibrium and ameliorate estrogen-deficient osteoporosis.

Cajaninstilbene Acid targets TNF-α-mediated mitochondrial translocation to restore osteogenic-osteoclastic coupling equilibrium and ameliorate estrogen-deficient osteoporosis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 23, 2026

Keap1-binding Loureirin B mitigates steroid-induced osteonecrosis of the femoral head by suppressing ROS-driven osteoclastogenesis.

Keap1-binding Loureirin B mitigates steroid-induced osteonecrosis of the femoral head by suppressing ROS-driven osteoclastogenesis.

Journal: Chinese medical journal

Published: September 28, 2025

Didymin halts knee osteoarthritis progression by targeting the GSK3B/5-LOX/11-HETE pathway to suppress chondrocyte ferroptosis.

Didymin halts knee osteoarthritis progression by targeting the GSK3B/5-LOX/11-HETE pathway to suppress chondrocyte ferroptosis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 07, 2025

Oxidative stress-related gene PRXL2A may participate in the occurrence and development of steroid-induced osteonecrosis of the femoral head by regulating osteoclast differentiation: A multi-omics analysis.

Oxidative stress-related gene PRXL2A may participate in the occurrence and development of steroid-induced osteonecrosis of the femoral head by regulating osteoclast differentiation: A multi-omics analysis.

Journal: Gene

Published: April 12, 2025

Targeting SIRT3 to regulate mitophagy-dependent ferroptosis for preventing glucocorticoid-induced osteoporosis.

Targeting SIRT3 to regulate mitophagy-dependent ferroptosis for preventing glucocorticoid-induced osteoporosis.

Journal: International journal of surgery (London, England)

Published: February 04, 2025

Drug-loaded nanoparticles for intra-articular injection.

Drug-loaded nanoparticles for intra-articular injection.

Journal: PloS one

Published: December 21, 2024

Isovitexin targets SIRT3 to prevent steroid-induced osteonecrosis of the femoral head by modulating mitophagy-mediated ferroptosis.

Isovitexin targets SIRT3 to prevent steroid-induced osteonecrosis of the femoral head by modulating mitophagy-mediated ferroptosis.

Journal: Bone research

Published: July 11, 2024

A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis.

A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis.

Journal: International immunopharmacology

Published: June 05, 2024

The pathomechanism of bone marrow edema in the femoral head necrosis with pericollapse stage.

The pathomechanism of bone marrow edema in the femoral head necrosis with pericollapse stage.

Journal: Scientific reports

Published: January 04, 2024

Therapeutic potential of a prominent dihydroxyflavanone pinocembrin for osteolytic bone disease: In vitro and in vivo evidence.

Therapeutic potential of a prominent dihydroxyflavanone pinocembrin for osteolytic bone disease: In vitro and in vivo evidence.

Journal: Journal of orthopaedic translation

Published: September 29, 2023

A novel Glycyrrhiza glabra extract liquiritin targeting NFATc1 activity and ROS levels to counteract ovariectomy-induced osteoporosis and bone loss in murine model.

A novel Glycyrrhiza glabra extract liquiritin targeting NFATc1 activity and ROS levels to counteract ovariectomy-induced osteoporosis and bone loss in murine model.

Journal: Frontiers in pharmacology

Published: September 02, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026